SciELO - Scientific Electronic Library Online

 
vol.34 issue4GLP-1 agonists plus SGLT2 inhibitors. Additive cardioprotective effects?The medical consultation for WhatsApp: A deterioration in the doctor-patient relationship. author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Medicina interna de México

Print version ISSN 0186-4866

Abstract

MURILLO-DOMINGUEZ, Guillermo. Shark cartilage: another oncological panacea. Med. interna Méx. [online]. 2018, vol.34, n.4, pp.614-618. ISSN 0186-4866.  https://doi.org/10.24245/mim.v34i4.2041.

Cancer is the third cause of death after cardiovascular diseases and diabetes mellitus. In the face of such a devastating epidemiological panorama, it is expected that a multitude of non-conventional, biological and non-biological “curative” therapies will emerge. Among the biological therapies is the shark cartilage, whose defenders of its use are based on the false premise that “sharks do not have cancer”, and when confronted, they claim conspiracy theories. Although the presence of an inhibitory factor of angiogenesis in the product has been demonstrated, clinical trials have not been conclusive as to a net beneficial effect in oncological patients. But the popular marketing of the substance is a business of several million dollars a year. It is prudent that doctors have knowledge, including possible side effects, to provide information to patients.

Keywords : Cancer; Biological therapies; Shark cartilage.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )